Supernus Pharmaceuticals Inc (SUPN)
Interest Expense
$2.32M
TTM · Period ending: · USD
SUPN Interest Expense
Latest reported$2.32Mperiod ending
Latest reported$2.32Mperiod ending
SUPN TTM Interest Expense (-$7.38M → $2.32M)
TTM interest expense
High-resolution chart · PNG
SUPN interest expense history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Interest Expense (USD) |
|---|---|
| 2,315,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 910,000 | |
| 2,415,000 | |
| 4,009,000 | |
| 5,733,000 | |
| 6,633,000 | |
| 7,070,000 | |
| 11,410,000 | |
| 15,611,000 | |
| 19,268,000 | |
| 23,423,000 | |
| 23,585,000 | |
| 23,748,000 | |
| 24,096,000 | |
| 23,754,000 | |
| 23,528,000 | |
| 23,102,000 | |
| 22,676,000 | |
| 22,791,000 | |
| 22,521,000 | |
| 22,424,000 | |
| 22,563,000 | |
| 18,111,000 | |
| 12,671,000 | |
| 7,261,000 | |
| 1,951,000 | |
| 1,582,000 | |
| 2,373,000 | |
| 3,424,000 | |
| 3,402,000 | |
| 2,532,000 | |
| 1,806,000 | |
| 892,000 | |
| 1,027,000 | |
| 1,229,000 | |
| 2,193,000 | |
| 3,190,000 | |
| 4,137,000 | |
| 4,963,000 | |
| 5,881,000 | |
| 7,462,000 | |
| 8,328,000 | |
| 7,848,000 | |
| 6,545,000 | |
| 4,555,000 | |
| 3,340,000 | |
| 3,575,000 | |
| -5,962,000 | |
| -6,343,000 | |
| -6,773,000 | |
| -7,375,000 | |
| 1,358,000 | |
| -8,350,699 |